Neliva

CRLCharles River Laboratories

HealthcareUpdated 2026-03-13
$155.46+1.83%
Open
$155.62
High
$158.76
Low
$153.04
Volume
988K
Market Cap
—
P/E Ratio
—
P/B Ratio
—
Enterprise Value
—

Get AI-Powered Analysis of CRL

Neliva uses real-time data and AI to provide deep research on Charles River Laboratories — including fundamentals, risk assessment, earnings review, and actionable insights.

Research CRL with AIDeep Analysis

Free to try — no account required for your first research.

About Charles River Laboratories (CRL)

Charles River Laboratories (CRL) is a publicly traded company in the Healthcare sector, listed as a component of the S&P 500 index.

Investors and analysts track CRL for its performance within the Healthcare sector. Using Neliva's AI-powered research tools, you can get comprehensive analysis including real-time pricing, fundamental analysis, technical indicators, news sentiment, and risk assessment — all in seconds.

Frequently Asked Questions

What is the current price of CRL?
As of 2026-03-13, CRL is trading at $155.46 (+1.83% today). Range: $153.04 — $158.76.
What is the P/E ratio of CRL?
Use Neliva to get the latest P/E ratio for CRL.
Is CRL a good stock to buy?
Whether CRL is a good investment depends on your goals and risk tolerance. Neliva’s AI provides comprehensive analysis including valuation, growth, risk factors, and analyst consensus.
What sector is CRL in?
Charles River Laboratories (CRL) is in the Healthcare sector of the S&P 500.

Related Healthcare Stocks

LLYEli Lilly and CompanyUNHUnitedHealth Group Inc.JNJJohnson & JohnsonABBVAbbVie Inc.MRKMerck & Co. Inc.TMOThermo Fisher Scientific Inc.ABTAbbott LaboratoriesISRGIntuitive Surgical Inc.

Research any stock with AI

Get real-time data, fundamental analysis, risk assessment, and actionable insights — powered by AI.

Get started free